09 May 2008
PharmaCoClinical ResearchR&D/BiotechSales/Mktg

Email:
Password:
Sign Up!
Search Resources Site Map

Sign up for our
newsletter
 

Privacy & Security
Terms and Conditions
Welcome to PharmiWeb.com
Real Time news
US clears new version of Novo Nordisk clot therapy
Therapeutics Daily
09 May 08 , 20:54

Closing Glance: Pharmaceutical stocks finish lower
Yahoo! Canada
09 May 08 , 20:52

Amgen spent $2.5M lobbying on biotech in the first quarter
Yahoo! Canada
09 May 08 , 20:52

ONYX PHARMACEUTICALS INC EPS Estimated At -0.08: Current Recommendation is Market Perform
Macro World Investor
09 May 08 , 20:47

Cyclacel Pharmaceuticals (CYCC) Reports a Q1 Loss
Street Insider
09 May 08 , 20:47

Latest Press Releases
ABPI Code Introduces New Requirements For Working With Health Professionals And Patient Groups
09 May 08
The Association of the British Pharmaceutical Ind.
Historically a Disappointment, Neuroprotective Drug Strategies Pursuing New Targets and Mechanisms
08 May 08
Applied Data Research
RTS Life Science Announces the Availability of New Sample Management Technical Paper ‘A New Paradigm in Sample Library Management and Replication’
08 May 08
The Scott Partnership

Latest Events
Formulation and Manufacturing of Pharmaceuticals
12 May 08 - 14 May 08
Chronic Opioid Therapy: Understanding Risk While Maximizing Analgesia
12 May 08 - 12 May 08
11th Annual Generics Supergenerics & Patent Strategies
12 May 08 - 13 May 08

PharmiWeb.com is the leading industry-sponsored portal for the Pharmaceutical sector, providing news, features, events, and a powerful jobs database - online and real-time. If you are in medical sales, clinical research, or any other role in the pharmaceutical industry, make PharmiWeb.com your first destination online.
pharmiweb.com today | 09 May 2008
NICE backs Merck KGaA’s Erbitux in head/neck cancers
The National Institute for Health and Clinical Excellence has issued a Final Appraisal Determination recommending the use of Merck KGaA’s Erbitux (cetuximab) in combination with radiotherapy for the treatment of locally-advanced head and neck cancer in National Health Service patients in England and Wales who are contraindicated to all forms of platinum based chemoradiotherapy.

more pharmiweb.com today stories
View article as featured on pharmatimes.com

Latest Features
Anti-Obesity Treatments 2007-2012
09 May 08

“By 2010, almost 50 percent of children in North America and 38 percent of those in the European Union will be overweight, research has found”.
What Is Crohn's Disease?
07 May 08
A Day in the Life of a Medical Sales Representativ
06 May 08

Philip Miles of Alchemy explains the ins and outs of the daily life for Medical Sales Reps.

Latest Poll
Who is mostly to blame for the increasing problem of obesity?
The Media
The Government
Each individual
The Food Industry
Educational Establishments
Parents
Other

Pharmiweb.com RSS Feed
Pharmiweb.com RSS Feed
Blog